RADFORSK, The Norwegian Radium Hospital Research Foundation strategic research area (2023-2028) (Co-PI) TARACAN: Targeted Radionuclide Therapy for disseminated cancer
South-Eastern Norway Regional Health Authority/Norwegian Cancer Society (2020-2024) Theranostic radiopharmaceuticals for metastatic cancer
South-Eastern Norway Regional Health Authority (2019-2024) A novel PET-based prediction platform for myeloma patients
South-Eastern Norway Regional Health Authority and CarciNor (2018-24) Clinical usefulness of advanced image analysis of 18F-FDG PET/CT for in vivo characterisation of neuroendocrine carcinomas
Civitan, The Alzheimer Research Fund (2018-2023) Amyloid imaging by 18F-Flutemetamol PET/CT and MRI – clinical value and quantitative reference levels
Tulipan A, Kratochwil C, Lilleby J, Lilleby W(2024) A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancer Urol Case Rep, 54, 102752 DOI 10.1016/j.eucr.2024.102752, PubMed 38779691
Abrahamsen BS, Tandstad T, Aksnessæther BY, Bogsrud TV, Castillejo M, Hernes E, Johansen H, Keil TMI, Knudtsen IS, Langørgen S, Selnæs KM, Bathen TF, Elschot M(2024) Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management J Magn Reson Imaging(in press) DOI 10.1002/jmri.29386, PubMed 38679841
Jacewicz M, Rud E, Lauritzen P, Baco E(2024) Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia BJU Int(in press) DOI 10.1111/bju.16383, PubMed 38679416